Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Identification of a chemical probe for NAADP by virtual screening.
Naylor E
,
Arredouani A
,
Vasudevan SR
,
Lewis AM
,
Parkesh R
,
Mizote A
,
Rosen D
,
Thomas JM
,
Izumi M
,
Ganesan A
,
Galione A
,
Churchill GC
.
???displayArticle.abstract???
Research into the biological role of the Ca(2+)-releasing second messenger NAADP (nicotinic acid adenine dinucleotide phosphate) has been hampered by a lack of chemical probes. To find new chemical probes for exploring NAADP signaling, we turned to virtual screening, which can evaluate millions of molecules rapidly and inexpensively. We used NAADP as the query ligand to screen the chemical library ZINC for compounds with similar three-dimensional shape and electrostatic properties. We tested the top-ranking hits in a sea urchin egg bioassay and found that one hit, Ned-19, blocks NAADP signaling at nanomolar concentrations. In intact cells, Ned-19 blocked NAADP signaling and fluorescently labeled NAADP receptors. Moreover, we show the utility of Ned-19 as a chemical probe by using it to demonstrate that NAADP is a key causal link between glucose sensing and Ca(2+) increases in mouse pancreatic beta cells.
Figure 2. Certain virtual screening hits have biological activity. (a) Relative antagonist activity of the hit compounds against NAADP-mediated Ca2+ release. Bars with an asterisk indicate inhibition significantly less than the control based on a one-tailed t-test with p ≤ 0.05. Hit compounds were present at 6-125 μM depending on their aqueous solubility (see Supplementary Methods) and NAADP was added at its EC50 (35 nM). (b) The virtual screening hit Ned-19 selectively inhibits NAADP-mediated Ca2+ release in a Ca2+-mobilizing bioassay (sea urchin egg homogenate; left panel). All three Ca2+-releasing second messengers release sequestered Ca2+ in the control when added at their half-maximal concentration (right trace). Traces show the fluorescence (Relative Fluorescence Units, RFU) from the Ca2+-reporting dye fluo-3. (c) Concentration-inhibition curves for Ned-19 on Ca2+ release mediated by the EC50 concentrations of inositol 1,4,5-trisphosphate (IP3; 1 μM), cyclic ADP-ribose (cADPR; 300 nM) and NAADP (35 nM). (d,e) Concentration-inhibition curves for the compounds Ned-19 (100 μM) (d) and Ned-20 (100 μM) (e) on NAADP-mediated Ca2+ release. (f) The compound Ned-19 competes with [32P]NAADP binding. “Con” is the amount of binding in the control. (g) Dissociation of Ned-19 (10 μM) and NAADP (10 nM) determined by the recovery of [32P]NAADP binding after 5 days of incubation. A value of 100 percent corresponds to about 1,500 counts per min. (h) Chemical structures of the ‘trans’ and ‘cis’ diastereomers of Ned-19. (i) Concentration-inhibition curves for Ned-19 inhibition of NAADP-medicated Ca2+ release. (j) Concentration-inhibition curves for Ned-19 on [32P]NAADP binding.
Figure 3. The virtual screening hit Ned-19 antagonizes Ca2+ signaling in intact cells. (a) Ned-19 (100 μM in the bath) inhibits NAADP-induced Ca2+ release in an intact sea urchin egg. Ca2+ was monitored with the Ca2+-reporting dye Oregon Green 488-BAPTA Dextran (10 μM, microinjected). NAADP was pressure microinjected (100 μM in the pipette) so that each injection delivered approximately 1 μM. (b) Ned-19 inhibits NAADP-induced Ca2+ increases in mouse pancreatic beta cells. Ca2+-dependent current traces are from beta cells that were voltage-clamped with a patch pipette containing 100 nM NAADP in the presence or absence of 100 μM Ned-19 in the bath.
Figure 4. The virtual screening hit Ned-19 is fluorescent and labels receptors in intact cells. (a) Excitation (368 nm) and emission (425 nm) spectra of Ned-19. Ned-19 was in dimethylsulfoxide at 4 mM. (b) Ned-19 but not Lysotracker Red labeling of pancreatic beta cells is resistant to the V-type proton pump inhibitor bafilomycin A1. Lyostracker red but not Ned-19 labeling is resistant to pre-treatment with NAADP-acetyoxymethyl ester (NAADP-AM). Scale bars, 5 μm.
Figure 5. The virtual screening hit Ned-19 reveals that glucose-induced Ca2+ increases require NAADP signaling. (a) Ned-19 inhibits glucose-induced Ca2+ oscillations. (b) Ned-20 does not affect glucose-induced Ca2+ increases. (c,d) Ned-19 reduces glucose-induced Ca2+ increases in a concentration-dependent manner. Islets were pre-incubated with the indicated concentration of Ned-19 for 30 min before the addition of 15 mM glucose. “Con” is the control. (e) Ned-19 does not affect the activation of voltage-gated Ca2+ channels. Cells were incubated in glucose (10 mM) and diazoxide (100 μM) and then depolarized with KCl (45 mM) in the presence and absence of Ned-19 (100 μM). (f) Ned-19 does not interfere with mitochondrial production of NAD(P)H. All cells were maintained in 3 mM glucose unless otherwise indicated.
Aarhus,
Activation and inactivation of Ca2+ release by NAADP+.
1996, Pubmed,
Echinobase
Aarhus,
Activation and inactivation of Ca2+ release by NAADP+.
1996,
Pubmed
,
Echinobase
Arredouani,
Contribution of the endoplasmic reticulum to the glucose-induced [Ca(2+)](c) response in mouse pancreatic islets.
2002,
Pubmed
Ashcroft,
Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells.
1985,
Pubmed
Billington,
Triazine dyes are agonists of the NAADP receptor.
2004,
Pubmed
,
Echinobase
Billington,
Role of the nicotinic acid group in NAADP receptor selectivity.
2005,
Pubmed
,
Echinobase
Billington,
PPADS is a reversible competitive antagonist of the NAADP receptor.
2007,
Pubmed
,
Echinobase
Billington,
Production and characterization of reduced NAADP (nicotinic acid-adenine dinucleotide phosphate).
2004,
Pubmed
,
Echinobase
Boström,
Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists.
2007,
Pubmed
Boström,
Assessing the performance of OMEGA with respect to retrieving bioactive conformations.
2003,
Pubmed
Brailoiu,
Nicotinic acid adenine dinucleotide phosphate potentiates neurite outgrowth.
2005,
Pubmed
Cancela,
Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells.
1999,
Pubmed
,
Echinobase
Churchill,
NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs.
2002,
Pubmed
,
Echinobase
Doman,
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B.
2002,
Pubmed
Dowden,
Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ release.
2006,
Pubmed
,
Echinobase
Drews,
Drug discovery: a historical perspective.
2000,
Pubmed
Galione,
The NAADP receptor: commentary on Billington et al.
2004,
Pubmed
,
Echinobase
Galione,
The NAADP receptor: new receptors or new regulation?
2005,
Pubmed
,
Echinobase
Galione,
NAADP receptors.
2005,
Pubmed
,
Echinobase
Genazzani,
Unique inactivation properties of NAADP-sensitive Ca2+ release.
1996,
Pubmed
,
Echinobase
Gerasimenko,
NAADP, cADPR and IP3 all release Ca2+ from the endoplasmic reticulum and an acidic store in the secretory granule area.
2006,
Pubmed
Giepmans,
The fluorescent toolbox for assessing protein location and function.
2006,
Pubmed
Giniatullin,
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling.
2005,
Pubmed
Hawkins,
Comparison of shape-matching and docking as virtual screening tools.
2007,
Pubmed
Irwin,
ZINC--a free database of commercially available compounds for virtual screening.
2005,
Pubmed
Islam,
Cyclic ADP-ribose in beta cells.
1993,
Pubmed
Jenkins,
A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes.
2004,
Pubmed
Johnson,
Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells.
2002,
Pubmed
Jorgensen,
The many roles of computation in drug discovery.
2004,
Pubmed
Lee,
A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose.
1995,
Pubmed
,
Echinobase
Lee,
Structural determinants of nicotinic acid adenine dinucleotide phosphate important for its calcium-mobilizing activity.
1997,
Pubmed
,
Echinobase
Lee,
Fluorescent analogs of NAADP with calcium mobilizing activity.
1998,
Pubmed
,
Echinobase
Lee,
Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling.
2005,
Pubmed
,
Echinobase
Lipinski,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
2001,
Pubmed
Masgrau,
NAADP: a new second messenger for glucose-induced Ca2+ responses in clonal pancreatic beta cells.
2003,
Pubmed
Mitchell,
Ryanodine receptor type I and nicotinic acid adenine dinucleotide phosphate receptors mediate Ca2+ release from insulin-containing vesicles in living pancreatic beta-cells (MIN6).
2003,
Pubmed
Nicholls,
Variable selection and model validation of 2D and 3D molecular descriptors.
2004,
Pubmed
Oprea,
Integrating virtual screening in lead discovery.
2004,
Pubmed
Parkesh,
Cell-permeant NAADP: a novel chemical tool enabling the study of Ca2+ signalling in intact cells.
2008,
Pubmed
,
Echinobase
Patel,
NAADP-induced Ca2+ release -- a new signalling pathway.
2004,
Pubmed
Rush,
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction.
2005,
Pubmed
Seghers,
Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion.
2000,
Pubmed
Shoichet,
Virtual screening of chemical libraries.
2004,
Pubmed
Takasawa,
Cyclic ADP-ribose in insulin secretion from pancreatic beta cells.
1993,
Pubmed
Tan,
Diversity-oriented synthesis: exploring the intersections between chemistry and biology.
2005,
Pubmed
Yamasaki,
Organelle selection determines agonist-specific Ca2+ signals in pancreatic acinar and beta cells.
2004,
Pubmed